WuXi STA breaks ground on new Delaware manufacturing facility
European Pharmaceutical Review
AUGUST 17, 2022
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The WuXi STA Middletown facility is expected to begin operations in 2025.
Let's personalize your content